BioCryst Pharmaceuticals Inc (BCRX)
7.05
-0.30
(-4.02%)
USD |
NASDAQ |
Nov 05, 16:00
7.06
+0.01
(+0.14%)
After-Hours: 19:08
BioCryst Pharmaceuticals Cash from Investing (Quarterly): -2.449M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -2.449M |
| March 31, 2024 | 28.76M |
| December 31, 2023 | -28.47M |
| September 30, 2023 | 23.12M |
| June 30, 2023 | -19.04M |
| March 31, 2023 | -107.11M |
| December 31, 2022 | 77.22M |
| September 30, 2022 | -69.54M |
| June 30, 2022 | -97.44M |
| March 31, 2022 | -38.47M |
| December 31, 2021 | -11.12M |
| September 30, 2021 | 7.747M |
| June 30, 2021 | 4.504M |
| March 31, 2021 | 14.67M |
| December 31, 2020 | 21.41M |
| September 30, 2020 | -34.06M |
| June 30, 2020 | -4.932M |
| March 31, 2020 | 10.72M |
| December 31, 2019 | 16.26M |
| September 30, 2019 | 23.51M |
| June 30, 2019 | 22.28M |
| March 31, 2019 | 15.88M |
| December 31, 2018 | -3.167M |
| September 30, 2018 | -9.525M |
| June 30, 2018 | 1.533M |
| Date | Value |
|---|---|
| March 31, 2018 | 15.93M |
| December 31, 2017 | -57.38M |
| September 30, 2017 | 1.963M |
| June 30, 2017 | -23.35M |
| March 31, 2017 | 14.13M |
| December 31, 2016 | -9.827M |
| September 30, 2016 | 21.95M |
| June 30, 2016 | 8.444M |
| March 31, 2016 | 2.707M |
| December 31, 2015 | -2.987M |
| September 30, 2015 | -18.14M |
| June 30, 2015 | 7.072M |
| March 31, 2015 | -3.948M |
| December 31, 2014 | -53.09M |
| September 30, 2014 | 4.865M |
| June 30, 2014 | 9.266M |
| March 31, 2014 | -1.023M |
| December 31, 2013 | -2.262M |
| September 30, 2013 | -5.809M |
| June 30, 2013 | 2.532M |
| March 31, 2013 | 2.072M |
| December 31, 2012 | 3.646M |
| September 30, 2012 | 11.68M |
| June 30, 2012 | -1.977M |
| March 31, 2012 | 11.54M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-107.11M
Minimum
Mar 2023
77.22M
Maximum
Dec 2022
-10.96M
Average
-2.449M
Median
Jun 2024
Cash from Investing (Quarterly) Benchmarks
| Novavax Inc | -372.71M |
| AIM ImmunoTech Inc | 0.826M |
| Perspective Therapeutics Inc | -3.295M |
| Protalix BioTherapeutics Inc | -0.18M |
| Armata Pharmaceuticals Inc | -1.366M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.368M |
| Cash from Financing (Quarterly) | -1.966M |
| Free Cash Flow | -85.80M |
| Free Cash Flow Per Share (Quarterly) | -0.0074 |
| Free Cash Flow to Equity (Quarterly) | 3.032M |
| Free Cash Flow to Firm (Quarterly) | 19.95M |
| Free Cash Flow Yield | -6.06% |